期刊文献+

腺病毒介导的Vasostatin基因对血管内皮细胞的作用 被引量:1

Effect of Vasostatin Gene Mediated by Adenovirus on the Proliferation and Apoptosis of Vascular Endothelial Cells
下载PDF
导出
摘要 目的研究腺病毒介导的Vasostatin基因对体外培养的血管内皮细胞增殖及凋亡的作用。方法采用MTT法观察Vasostatin基因对人脐静脉血管内皮细胞ECV304的体外细胞增殖的影响。采用透射电镜、TUNEL与Hoechst33258双重荧光染色、流式细胞仪AnnexinV/PI双染法,检测腺病毒介导的Vasostatin基因作用后人脐静脉血管内皮细胞的凋亡。结果Ad-Vasostatin(MO I分别为25和50)作用72 h后,ECV304细胞数显著少于PBS组和Ad-lacZ组(P<0.05);透射电镜下及TUNEL/Hoechst33258双重荧光染色,ECV304细胞出现典型的凋亡形态学改变。以MO I为50的Ad-Vasostatin处理ECV304细胞72 h后,细胞凋亡率为(15.70±0.84)%,PBS组为(2.54±0.83)%,Ad-lacZ组为(2.34±0.79)%,三组比较均有显著性差异(P<0.01)。结论腺病毒介导的Vasostatin基因可显著抑制人脐静脉血管内皮细胞ECV304的体外细胞增殖,同时对人脐静脉血管内皮细胞的凋亡具有诱导作用。 Objective To investigate the effect of vasostatin mediated by adenovirus on the proliferation and apoptosis of vascular endothelial cells in vitro. Methods The effects of vasostatin gene on the proliferation of ECV304 cells were measured by MTT assay. Morphological changes of ECV304 cells were observed under electron microscopy. Apoptosis was determined by Hoechst33258/TUNEL staining, and by FCM with Annexin V/P1 costaining. Results In the cellular proliferarion assay in vitro, the number of ECV304 cells in Ad-Vasostatin group was much smaller than that in Ad-lacZ group and PBS group (P 〈 0.05). After 72 h of treatment with Ad-Vasostatin, the ECV304 cells had characteristics of apoptosis, as revealed by electron microscopy and Hoechst33258/TUNEL costaining. The apoptosis rate in Ad-Vasostatin group (15.70 ± 0.84)% was much higher than that in Ad-lacZ group (2.34±0.79)% and PBS group (2.54±0.83)% (P〈0.01). Conclusion The vasostatin gene mediated by adenovirus has an inhibitory effect on the proliferation of human umbilical vein endothelium cells ECV304 in vitro, and could induce the apoptosis of human umbilical vein endothelium cells in vitro.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2006年第5期511-515,共5页 Journal of Shanghai Jiao tong University:Medical Science
关键词 Vasostatin基因 血管内皮细胞 增殖 凋亡 基因治疗 Vasostatin gene vascular endothelial cells proliferation apoptosis gene therapy
  • 相关文献

参考文献19

  • 1Pike SE,Yao L,Jones KD et al.Vasostatin,a calreticulin fragment,inhibits angiogenesis and suppresses tumor growth[J].J Exp Med,1998,188 (12):2349-2356.
  • 2Li L,Yuan YZ,Lu J,et al.Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice[J].Gut,2006,55 (2):259-265.
  • 3Li L,Yuan YZ,Zhang YP,et al.Construction and identification of recombinant adenovirus carrying vasostatin gene[J].J Gastroenterol Hepato1,2004,19 (S5):A595-596.
  • 4Li L,Yuan YZ,Xia L,et al.Adenovirus-mediated vasostatin gene transfer in the treatment of pancreatic cancer[J].Gastroenterology,2005,128(4,S2):A453.
  • 5李雷,袁耀宗,章永平,乔敏敏,卢健.Vasostatin基因重组腺病毒载体的构建及其对胰腺癌生长的抑制作用[J].肿瘤,2004,24(6):538-541. 被引量:4
  • 6李雷,袁耀宗,章永平,乔敏敏,卢健.Vasostatin基因对胰腺癌血管生成的抑制作用[J].中华消化杂志,2005,25(10):590-593. 被引量:4
  • 7Folkman J.Fundamental concepts of the angiogenic process[J].Curr Mol Med,2003,3(7):643 -651.
  • 8Folkman J.Role of angiogenesis in tumor growth and metastasis[J].Semin Oncol,2002,29 (6 Suppl 16):15-18.
  • 9Folkman J.Angiogenesis inhibitors:a new class of drugs[J].Cancer Biol Ther,2003,2(4 Suppl 1):S127 -S133.
  • 10Satchi-Fainaro R,Mamluk R,Wang L,et al.Inhibition of vessel permeability by TNP-470 and its polymer conjugate,caplostatin[J].Cancer Cell,2005,7(3):251-261.

二级参考文献17

  • 1李雷,袁耀宗,章永平,乔敏敏,卢健.Vasostatin基因重组腺病毒载体的构建及其对胰腺癌生长的抑制作用[J].肿瘤,2004,24(6):538-541. 被引量:4
  • 2McCauliffe DP, Lux FA, Lieu TS, et al. Molecular cloning,expression, and chromosome 19 localization of a human Ro/SS-A autoantigen[J]. J Clin Invest, 1990,85 : 1379
  • 3Pike SE, Yao L, Jones KD, et al. Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth[J]. J Exp Med, 1998,188: 2349
  • 4Xiao F, Wei Y, Yang L, et al. A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin[J]. Gene Ther, 2002,9:1207
  • 5Yao L, Pike SE, Setsuda J, et al. Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12[J]. Blood, 2000,96: 1900
  • 6Francis PJ, Stout JT. Gene therapy and control of angiogenesis[J]. Ophthalmol Clin North Am , 2003, 16:575
  • 7St George JA. Gene therapy progress and prospects: adenoviral vectors[J]. Gene Ther, 2003, 10: 1135-1141.
  • 8He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses[J]. Proc Natl Acad Sci U S A ,1998, 95:2509
  • 9Pike SE, Yao L, Setsuda J, et al. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth[J]. Blood, 1999, 94:2461
  • 10Yeo CJ. Pancreatic cancer: 1998 update. J Am Coll Surg, 1998,187:429-442.

共引文献5

同被引文献14

  • 1李雷,袁耀宗,章永平,乔敏敏,卢健.Vasostatin基因重组腺病毒载体的构建及其对胰腺癌生长的抑制作用[J].肿瘤,2004,24(6):538-541. 被引量:4
  • 2李雷,袁耀宗,章永平,乔敏敏,卢健.Vasostatin基因对胰腺癌血管生成的抑制作用[J].中华消化杂志,2005,25(10):590-593. 被引量:4
  • 3李雷,袁耀宗,章永平,乔敏敏,卢健.Vasostatin基因对胰腺癌细胞和血管内皮细胞增殖的影响[J].胰腺病学,2006,6(1):12-15. 被引量:2
  • 4Hida K, Hida Y, Shindoh M. Understanding tumor endothelial cell abnormalities to develop ideal anti angiogenic therapies. Cancer Sci, 2008,99:459-466.
  • 5Taraboletti G, Giavazzi R. Modelling approaches for angiogenesis. Eur J Cancer, 2004,40:881-889.
  • 6Li L, Yuan YZ, Lu J, et al. Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice. Gut, 2006,55:259-265.
  • 7Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature, 2001,414: 105-111.
  • 8Rak J. Is cancer stem cell a cell, or a multicellular unit capable of inducing angiogenesis?. Med Hypotheses, 2006, 66 : 601-604.
  • 9Fang S, Salven P. Stem cells in t.umor angiogenesis. J Mol Cell Cardiol, 2011,50:290-295.
  • 10Rahman M, Deleyrolle L, Vedam-Mai V, et al. The cancer stem cell hypothesis: failures and pitfalls. Neurosurgery, 2011,68 : 531-545.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部